David A. Wilcox

2.5k total citations
48 papers, 1.8k citations indexed

About

David A. Wilcox is a scholar working on Hematology, Immunology and Allergy and Genetics. According to data from OpenAlex, David A. Wilcox has authored 48 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Hematology, 11 papers in Immunology and Allergy and 9 papers in Genetics. Recurrent topics in David A. Wilcox's work include Platelet Disorders and Treatments (24 papers), Hemophilia Treatment and Research (14 papers) and Cell Adhesion Molecules Research (11 papers). David A. Wilcox is often cited by papers focused on Platelet Disorders and Treatments (24 papers), Hemophilia Treatment and Research (14 papers) and Cell Adhesion Molecules Research (11 papers). David A. Wilcox collaborates with scholars based in United States, France and United Kingdom. David A. Wilcox's co-authors include Juan Fang, Qizhen Shi, Robert R. Montgomery, David X. Zhang, Scot A. Fahs, Peter J. Newman, David D. Gutterman, Rongshan Li, Aaron H. Bubolz and Suelhem A. Mendoza and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

David A. Wilcox

47 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Wilcox United States 24 932 478 434 258 226 48 1.8k
Anne Rensing‐Ehl Germany 21 134 0.1× 602 1.3× 175 0.4× 286 1.1× 33 0.1× 27 1.7k
Cédric Le Maréchal France 28 390 0.4× 355 0.7× 356 0.8× 778 3.0× 11 0.0× 76 2.1k
Dapeng Wang United States 19 241 0.3× 494 1.0× 102 0.2× 288 1.1× 18 0.1× 44 1.4k
Joyce E. Fox United States 20 434 0.5× 505 1.1× 498 1.1× 39 0.2× 133 0.6× 43 1.6k
Wakako Yamada Japan 14 353 0.4× 661 1.4× 100 0.2× 159 0.6× 15 0.1× 19 1.7k
Jonathan Hoggatt United States 24 778 0.8× 662 1.4× 234 0.5× 436 1.7× 25 0.1× 58 1.8k
Gary D. Hunter United Kingdom 6 781 0.8× 214 0.4× 34 0.1× 53 0.2× 134 0.6× 7 1.2k
Glennda Smithson United States 21 154 0.2× 480 1.0× 251 0.6× 292 1.1× 242 1.1× 41 1.7k
Tamotsu Miyazaki Japan 19 315 0.3× 424 0.9× 70 0.2× 137 0.5× 45 0.2× 88 1.5k
Paula Herrero Gascon United States 20 364 0.4× 403 0.8× 75 0.2× 289 1.1× 21 0.1× 36 1.3k

Countries citing papers authored by David A. Wilcox

Since Specialization
Citations

This map shows the geographic impact of David A. Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Wilcox more than expected).

Fields of papers citing papers by David A. Wilcox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Wilcox. The network helps show where David A. Wilcox may publish in the future.

Co-authorship network of co-authors of David A. Wilcox

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Wilcox. A scholar is included among the top collaborators of David A. Wilcox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Wilcox. David A. Wilcox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anishkin, Andriy, et al.. (2025). Phosphorylation of distal C-terminal residues promotes TRPV4 channel activation in response to arachidonic acid. Journal of Biological Chemistry. 301(3). 108260–108260. 1 indexed citations
2.
Koukouritaki, Sevasti B., Katrina Ashworth, Juan Fang, et al.. (2023). A single F153Sβ3 mutation causes constitutive integrin αIIbβ3 activation in a variant form of Glanzmann thrombasthenia. Blood Advances. 7(13). 3180–3191. 1 indexed citations
3.
Nishijima, Yoshinori, Natalya S. Zinkevich, Juan Fang, et al.. (2022). NADPH oxidase 4 contributes to TRPV4-mediated endothelium-dependent vasodilation in human arterioles by regulating protein phosphorylation of TRPV4 channels. Basic Research in Cardiology. 117(1). 24–24. 8 indexed citations
4.
Schroeder, Jocelyn A., Juan Fang, Weiqing Jing, et al.. (2021). Thromboelastometry assessment of hemostatic properties in various murine models with coagulopathy and the effect of factor VIII therapeutics. Journal of Thrombosis and Haemostasis. 19(10). 2417–2427. 6 indexed citations
5.
Anishkin, Andriy, Natalya S. Zinkevich, Yoshinori Nishijima, et al.. (2018). Transient receptor potential vanilloid 4 (TRPV4) activation by arachidonic acid requires protein kinase A–mediated phosphorylation. Journal of Biological Chemistry. 293(14). 5307–5322. 58 indexed citations
6.
Ristow, Laura C., Yi‐Pin Lin, Hiromi Satō, et al.. (2015). Integrin binding byBorrelia burgdorferi P66 facilitates dissemination but is not required for infectivity. Cellular Microbiology. 17(7). 1021–1036. 37 indexed citations
7.
Schroeder, Jocelyn A., et al.. (2014). In vivo enrichment of genetically manipulated platelets corrects the murine hemophilic phenotype and induces immune tolerance even using a low multiplicity of infection. Journal of Thrombosis and Haemostasis. 12(8). 1283–1293. 30 indexed citations
8.
Fang, Juan, et al.. (2013). C560Rβ3 caused platelet integrin αIIbβ3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality. Journal of Thrombosis and Haemostasis. 11(6). 1163–1171. 18 indexed citations
9.
Nurden, Paquita, Alan T. Nurden, Timothy C. Nichols, et al.. (2013). Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A. Nature Communications. 4(1). 2773–2773. 93 indexed citations
10.
Gao, Cunji, Brian Boylan, Juan Fang, et al.. (2011). Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. Blood. 117(18). 4946–4952. 87 indexed citations
11.
Ghevaert, Cédric, David A. Wilcox, Juan Fang, et al.. (2008). Developing recombinant HPA-1a–specific antibodies with abrogated Fcγ receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia. Journal of Clinical Investigation. 118(8). 2929–38. 27 indexed citations
12.
Shi, Qizhen, David A. Wilcox, Scot A. Fahs, et al.. (2007). Lentivirus‐mediated platelet‐derived factor VIII gene therapy in murine haemophilia A. Journal of Thrombosis and Haemostasis. 5(2). 352–361. 109 indexed citations
13.
Shi, Qizhen, David A. Wilcox, Patricia A. Morateck, et al.. (2004). Targeting platelet GPIbα transgene expression to human megakaryocytes and forming a complete complex with endogenous GPIbβ and GPIX. Journal of Thrombosis and Haemostasis. 2(11). 1989–1997. 23 indexed citations
14.
Niemeyer, Glenn P., et al.. (2003). Correction of a large animal model of type I Glanzmann's thrombasthenia by nonmyeloablative bone marrow transplantation. Experimental Hematology. 31(12). 1357–1362. 14 indexed citations
15.
Wilcox, David A., Qizhen Shi, Paquita Nurden, et al.. (2003). Induction of megakaryocytes to synthesize and store a releasable pool of human factor VIII. Journal of Thrombosis and Haemostasis. 1(12). 2477–2489. 44 indexed citations
16.
Wilcox, David A. & G C White. (2003). Gene therapy for platelet disorders: studies with Glanzmann's thrombasthenia. Journal of Thrombosis and Haemostasis. 1(11). 2300–2311. 24 indexed citations
17.
Shi, Qizhen, David A. Wilcox, Scot A. Fahs, Philip A. Kroner, & Robert R. Montgomery. (2003). Expression of human factor VIII under control of the platelet-specific αIIb promoter in megakaryocytic cell line as well as storage together with VWF. Molecular Genetics and Metabolism. 79(1). 25–33. 45 indexed citations
18.
Wilcox, David A., Cathy Paddock, Suzanne Lyman, Joan Cox Gill, & Peter J. Newman. (1995). Glanzmann thrombasthenia resulting from a single amino acid substitution between the second and third calcium-binding domains of GPIIb. Role of the GPIIb amino terminus in integrin subunit association.. Journal of Clinical Investigation. 95(4). 1553–1560. 60 indexed citations
19.
Jones, Stanton L. & David A. Wilcox. (1993). Religious values in secular theories of psychotherapy.. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne Rensing‐Ehl Breakdown of academic impact, for papers by Cédric Le Maréchal Breakdown of academic impact, for papers by Dapeng Wang Breakdown of academic impact, for papers by Joyce E. Fox Breakdown of academic impact, for papers by Wakako Yamada Breakdown of academic impact, for papers by Jonathan Hoggatt Breakdown of academic impact, for papers by Gary D. Hunter Breakdown of academic impact, for papers by Glennda Smithson Breakdown of academic impact, for papers by Tamotsu Miyazaki Breakdown of academic impact, for papers by Paula Herrero Gascon
Rankless by CCL
2026